Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Solomon

Showing results (11-20 of 1,421) with videos related to

Pageof 143
Sort By:
Drugs|July 11, 2006
ACE inhibitors and angiotensin receptor antagonists and the incidence of new-onset diabetes mellitus: an emerging themeDavid Aguilar, Scott D Solomon
European Heart Journal|September 30, 2015
Beyond ejection fraction: an integrative approach for assessment of cardiac structure and function in heart failureMaja Cikes, Scott D Solomon
Cardiology Clinics|October 22, 2008
Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular riskOrly Vardeny, Scott D Solomon
JACC. Heart Failure|February 8, 2023
Reply: Blood Pressure and Lack of Association With Treatment Benefits of Dapagliflozin in HFpEF and HFmrEFSenthil Selvaraj, Scott D Solomon
The New England Journal of Medicine|May 20, 2020
Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19. ReplyMuthiah Vaduganathan, Scott D Solomon
Current Heart Failure Reports|January 29, 2008
Optimizing care of heart failure after acute MI with an aldosterone receptor antagonistAnil Verma, Scott D Solomon
European Heart Journal|November 19, 2016
Influenza vaccination: a one-shot deal to reduce cardiovascular eventsOrly Vardeny, Scott D Solomon
Heart Failure Clinics|September 14, 2014
Management strategies for heart failure with preserved ejection fractionAli Vazir, Scott D Solomon
European Heart Journal|March 27, 2018
Expanding the global borders of heart failure: the SHOP and PEOPLE studiesMuthiah Vaduganathan, Scott D Solomon
Current Opinion in Cardiology|June 7, 2006
Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trialsMaria Tokmakova, Scott D Solomon
Pageof 143

Showing results (11-20 of 1,421) with videos related to

Sort By:
Pageof 143
Drugs|July 11, 2006
ACE inhibitors and angiotensin receptor antagonists and the incidence of new-onset diabetes mellitus: an emerging themeDavid Aguilar, Scott D Solomon
European Heart Journal|September 30, 2015
Beyond ejection fraction: an integrative approach for assessment of cardiac structure and function in heart failureMaja Cikes, Scott D Solomon
Cardiology Clinics|October 22, 2008
Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular riskOrly Vardeny, Scott D Solomon
JACC. Heart Failure|February 8, 2023
Reply: Blood Pressure and Lack of Association With Treatment Benefits of Dapagliflozin in HFpEF and HFmrEFSenthil Selvaraj, Scott D Solomon
The New England Journal of Medicine|May 20, 2020
Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19. ReplyMuthiah Vaduganathan, Scott D Solomon
Current Heart Failure Reports|January 29, 2008
Optimizing care of heart failure after acute MI with an aldosterone receptor antagonistAnil Verma, Scott D Solomon
European Heart Journal|November 19, 2016
Influenza vaccination: a one-shot deal to reduce cardiovascular eventsOrly Vardeny, Scott D Solomon
Heart Failure Clinics|September 14, 2014
Management strategies for heart failure with preserved ejection fractionAli Vazir, Scott D Solomon
European Heart Journal|March 27, 2018
Expanding the global borders of heart failure: the SHOP and PEOPLE studiesMuthiah Vaduganathan, Scott D Solomon
Current Opinion in Cardiology|June 7, 2006
Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trialsMaria Tokmakova, Scott D Solomon
Pageof 143